Inke S.A: APIs manufacturing plant.
01 1Inke S.A
02 1Transo-Pharm USA LLC
03 1Medichem S.A
04 1Shandong Loncom Pharmaceutical
05 1Aurobindo Pharma Limited
06 1Beijing Breathgreen Healthcare
07 1Beijing Fukangren Biopharmaceutical
08 1Beijing Sjar Technology Development
09 1Cipla
10 1MSN Laboratories
11 1Maithri Drugs
12 1Mankind Pharma
13 1Sichuan Renan Pharmaceutical
01 5China
02 5India
03 2Spain
04 1U.S.A
01 6Active
02 7Blank
01 13Blank
01 13Blank
01 1WC-0349
02 12Blank
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-01
Pay. Date : 2022-03-17
DMF Number : 36481
Submission : 2022-07-27
Status : Active
Type : II
NDC Package Code : 64567-0029
Start Marketing Date : 2022-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CN |
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-05-10
Pay. Date : 2022-04-11
DMF Number : 36861
Submission : 2022-04-19
Status : Active
Type : II
NDC Package Code : 53296-0127
Start Marketing Date : 2020-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-07-12
Pay. Date : 2022-05-26
DMF Number : 37139
Submission : 2022-05-27
Status : Active
Type : II
NDC Package Code : 59651-683
Start Marketing Date : 2023-12-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-05-20
Pay. Date : 2022-05-13
DMF Number : 36737
Submission : 2022-05-06
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-07-25
Pay. Date : 2022-06-17
DMF Number : 36767
Submission : 2022-03-31
Status : Active
Type : II
Date of Issue : 2022-09-02
Valid Till : 2025-05-05
Written Confirmation Number : WC-0349
Address of the Firm :
NDC Package Code : 54893-0122
Start Marketing Date : 2022-01-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-07-25
Pay. Date : 2022-06-01
DMF Number : 36771
Submission : 2022-02-18
Status : Active
Type : II
A Revefenacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Revefenacin, including repackagers and relabelers. The FDA regulates Revefenacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Revefenacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Revefenacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Revefenacin supplier is an individual or a company that provides Revefenacin active pharmaceutical ingredient (API) or Revefenacin finished formulations upon request. The Revefenacin suppliers may include Revefenacin API manufacturers, exporters, distributors and traders.
click here to find a list of Revefenacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 13 companies offering Revefenacin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?